• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

EB病毒相关噬血细胞性淋巴组织细胞增生症合并严重凝血障碍和机会性感染：1例幸存者的病例报告

EBV-associated hemophagocytic lymphohistiocytosis complicated by severe coagulation disorders and opportunistic infections: case report of a survivor.

作者信息

Saevels Kirsten, Robert Dominique, Van den Broeck Sylvie, Malfait Ronald, Gadisseur Alain, Jorens Philippe, Verlinden Anke

机构信息

Department of Hematology Antwerp University Hospital Edegem Belgium.

Department of Intensive Care Medicine Antwerp University Hospital Edegem Belgium.

出版信息

Clin Case Rep. 2017 Nov 29;6(1):115-118. doi: 10.1002/ccr3.1301. eCollection 2018 Jan.

DOI:10.1002/ccr3.1301
PMID:29375849
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5771920/
Abstract

The possibility of hemophagocytic lymphohistiocytosis should always be kept in mind when examining/treating a patient with fever of unknown origin and sepsis-like symptoms. Early diagnosis leading to prompt initiation of immunosuppressive therapy as well as aggressive supportive care, including correction of coagulation abnormalities and treatment of opportunistic infections, can decrease mortality.

摘要

在检查/治疗不明原因发热和脓毒症样症状的患者时，应始终考虑噬血细胞性淋巴组织细胞增生症的可能性。早期诊断并迅速开始免疫抑制治疗以及积极的支持治疗，包括纠正凝血异常和治疗机会性感染，可降低死亡率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a51/5771920/bff3bcc01cf7/CCR3-6-115-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a51/5771920/d389677cf663/CCR3-6-115-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a51/5771920/bff3bcc01cf7/CCR3-6-115-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a51/5771920/d389677cf663/CCR3-6-115-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a51/5771920/bff3bcc01cf7/CCR3-6-115-g002.jpg

相似文献

1
EBV-associated hemophagocytic lymphohistiocytosis complicated by severe coagulation disorders and opportunistic infections: case report of a survivor.EB病毒相关噬血细胞性淋巴组织细胞增生症合并严重凝血障碍和机会性感染：1例幸存者的病例报告
Clin Case Rep. 2017 Nov 29;6(1):115-118. doi: 10.1002/ccr3.1301. eCollection 2018 Jan.
2
[Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis: Rarity and Severity in an Immunocompetent Adult].[爱泼斯坦-巴尔病毒相关噬血细胞性淋巴组织细胞增生症：免疫功能正常成年人中的罕见性与严重性]
Acta Med Port. 2019 Feb 1;32(1):78-80. doi: 10.20344/amp.9474.
3
Epstein-Barr virus-induced hemophagocytic lymphohistiocytosis and X-linked lymphoproliferative disease: a mimicker of sepsis in the pediatric intensive care unit.爱泼斯坦-巴尔病毒诱导的噬血细胞性淋巴组织细胞增生症和X连锁淋巴增殖性疾病：儿科重症监护病房中脓毒症的模仿者
Pediatrics. 2007 May;119(5):e1212-8. doi: 10.1542/peds.2006-1534. Epub 2007 Apr 2.
4
[A case of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in an elderly woman].[一位老年女性的爱泼斯坦-巴尔病毒相关噬血细胞性淋巴组织细胞增生症病例]
Nihon Ronen Igakkai Zasshi. 2019;56(4):525-531. doi: 10.3143/geriatrics.56.525.
5
A case of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with severe cardiac complications.一例伴有严重心脏并发症的爱泼斯坦-巴尔病毒相关噬血细胞性淋巴组织细胞增生症。
BMC Pediatr. 2016 Oct 28;16(1):172. doi: 10.1186/s12887-016-0718-3.
6
[Clinical and morphological diagnosis of secondary hemophagocytic lymphohistiocytosis].继发性噬血细胞性淋巴组织细胞增生症的临床与形态学诊断
Arkh Patol. 2020;82(6):44-49. doi: 10.17116/patol20208206144.
7
[Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis subsequent to rabbit antithymocyte globulin administration and successfully treated with rituximab in a patient with aplastic anemia].再生障碍性贫血患者在使用兔抗胸腺细胞球蛋白后发生的与 Epstein-Barr 病毒相关的噬血细胞性淋巴组织细胞增生症，并成功用利妥昔单抗治疗
Rinsho Ketsueki. 2018;59(4):407-413. doi: 10.11406/rinketsu.59.407.
8
[Clinical analysis and follow-up study of Epstein-Barr virus associated-hemophagocytic lymphohistiocytosis in childhood].儿童Epstein-Barr病毒相关噬血细胞性淋巴组织细胞增生症的临床分析及随访研究
Zhonghua Er Ke Za Zhi. 2010 Feb;48(2):121-6.
9
Severe hemorrhagic coagulopathy with hemophagocytic lymphohistiocytosis secondary to Epstein-Barr virus-associated T-cell lymphoproliferative disorder.继发于 EBV 相关 T 细胞淋巴组织增殖性疾病的严重出血性凝血障碍伴噬血细胞性淋巴组织细胞增生症。
Pediatr Crit Care Med. 2013 May;14(4):e176-81. doi: 10.1097/PCC.0b013e3182720f94.
10
Identification of a novel CCDC22 mutation in a patient with severe Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis and aggressive natural killer cell leukemia.鉴定一名严重 EBV 相关噬血细胞性淋巴组织细胞增生症和侵袭性自然杀伤细胞白血病患者中的新型 CCDC22 突变。
Int J Hematol. 2019 Jun;109(6):744-750. doi: 10.1007/s12185-019-02595-0. Epub 2019 Jan 31.

引用本文的文献

1
Hemophagocytic Lymphohistiocytosis in the adult critically ill: a narrative review of case reports and case series.成人危重症患者中的噬血细胞性淋巴组织细胞增生症：病例报告和病例系列的叙述性综述
Front Med (Lausanne). 2025 Sep 8;12:1622770. doi: 10.3389/fmed.2025.1622770. eCollection 2025.
2
Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024: part 4-trauma, burn, obstetrics, acute pancreatitis/liver failure, and others.《2024年日本弥散性血管内凝血管理临床实践指南：第4部分——创伤、烧伤、产科、急性胰腺炎/肝衰竭及其他》
Int J Hematol. 2025 May;121(5):633-652. doi: 10.1007/s12185-025-03918-0. Epub 2025 Jan 31.
3

本文引用的文献

1
Coagulation Disorders and Bleedings in Critically Ill Patients With Hemophagocytic Lymphohistiocytosis.噬血细胞性淋巴组织细胞增生症危重症患者的凝血障碍与出血
Medicine (Baltimore). 2015 Oct;94(40):e1692. doi: 10.1097/MD.0000000000001692.
2
Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposide.162例成人噬血细胞综合征队列中早期死亡的预后因素：触发疾病及依托泊苷早期治疗的影响
Br J Haematol. 2015 Jan;168(1):63-8. doi: 10.1111/bjh.13102. Epub 2014 Aug 26.
3
Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens.
Scoping review on diagnostic criteria and investigative approach in sepsis of unknown origin in critically ill patients.
危重症患者不明原因脓毒症诊断标准及检查方法的范围综述
J Intensive Care. 2022 Sep 11;10(1):44. doi: 10.1186/s40560-022-00633-4.
4
A Case of Severe Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis Successfully Treated With High Dose Steroids and Ganciclovir.一例严重的爱泼斯坦-巴尔病毒相关噬血细胞性淋巴组织细胞增生症经大剂量类固醇和更昔洛韦成功治疗的病例
Cureus. 2022 Jun 15;14(6):e25952. doi: 10.7759/cureus.25952. eCollection 2022 Jun.
5
Hemophagocytic lymphohistiocytosis presented with fever of unknown origin: A case study and literature review.以不明原因发热为表现的噬血细胞性淋巴组织细胞增生症：一例病例报告及文献综述
Clin Case Rep. 2021 Mar 8;9(4):2350-2355. doi: 10.1002/ccr3.4033. eCollection 2021 Apr.
利妥昔单抗联合化疗免疫治疗方案治疗 EBV 诱导的噬血细胞性淋巴组织细胞增生症。
Br J Haematol. 2013 Aug;162(3):376-82. doi: 10.1111/bjh.12386. Epub 2013 May 21.
4
Clinical features of adult patients with secondary hemophagocytic lymphohistiocytosis from causes other than lymphoma: an analysis of treatment outcome and prognostic factors.成人非淋巴瘤继发噬血细胞性淋巴组织细胞增生症的临床特征：治疗结果和预后因素分析。
Ann Hematol. 2012 Jun;91(6):897-904. doi: 10.1007/s00277-011-1380-3. Epub 2011 Dec 8.
5
How I treat hemophagocytic lymphohistiocytosis.噬血细胞性淋巴组织细胞增生症的治疗方法。
Blood. 2011 Oct 13;118(15):4041-52. doi: 10.1182/blood-2011-03-278127. Epub 2011 Aug 9.
6
HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.HLH-2004：噬血细胞性淋巴组织细胞增生症的诊断与治疗指南。
Pediatr Blood Cancer. 2007 Feb;48(2):124-31. doi: 10.1002/pbc.21039.